{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:31:03Z","timestamp":1781152263857,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T00:00:00Z","timestamp":1752192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00415-025-13206-w","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T14:27:14Z","timestamp":1752244034000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of the Italian cohort of late-onset Pompe disease (LOPD) patients after 10 and 15\u00a0years of therapy with alglucosidase alfa"],"prefix":"10.1007","volume":"272","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4061-4261","authenticated-orcid":false,"given":"T.","family":"Mongini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Gadaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Alonge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Vercelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Stura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Ravaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ruggiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Fiumara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Barone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Servidei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Sancricca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Siciliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Tonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Pegoraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Filosto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Barp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Crescimanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Toscano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Italian Myology Association (AIM) Study Group for Pompe Disease","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Migliaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Urbano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Arena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Falcone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Porcino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Rodolico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. G.","family":"Croce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zoppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Primiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Carlesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Schirinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Torri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dallatorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Verriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Vattemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Capece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Riguzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Caria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Risi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Diella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bonanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gallone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Giacopuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Tanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Stano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zuccarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Brighina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,11]]},"reference":[{"issue":"9","key":"13206_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16383","volume":"31","author":"B Schoser","year":"2024","unstructured":"Schoser B, van der Beek NE, Broomfield A et al (2024) Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024. Eur J Neurol 31(9):e16383. https:\/\/doi.org\/10.1111\/ene.16383. (PMID: 38873957; PMCID: PMC11295151)","journal-title":"Eur J Neurol"},{"issue":"4","key":"13206_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00415-016-8219-8","volume":"264","author":"B Schoser","year":"2017","unstructured":"Schoser B, Stewart A, Kanters S et al (2017) Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis. J Neurol 264(4):621\u2013630. https:\/\/doi.org\/10.1007\/s00415-016-8219-8. (PMID: 27372449)","journal-title":"J Neurol"},{"issue":"19","key":"13206_CR3","doi-asserted-by":"publisher","first-page":"e1756","DOI":"10.1212\/WNL.0000000000008441","volume":"93","author":"L Harlaar","year":"2019","unstructured":"Harlaar L, Hogrel JY, Perniconi B et al (2019) Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease. Neurology 93(19):e1756\u2013e1767. https:\/\/doi.org\/10.1212\/WNL.0000000000008441. (PMID: 31619483; PMCID: PMC6946483)","journal-title":"Neurology"},{"issue":"7","key":"13206_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1750-1172-7-88","volume":"12","author":"NE van der Beek","year":"2012","unstructured":"van der Beek NE, de Vries JM, Hagemans ML et al (2012) Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study. Orphanet J Rare Dis 12(7):88. https:\/\/doi.org\/10.1186\/1750-1172-7-88. (PMID: 23147228; PMCID: PMC3551719)","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"13206_CR5","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/mus.21025","volume":"38","author":"JH Wokke","year":"2008","unstructured":"Wokke JH, Escolar DM, Pestronk A et al (2008) Clinical features of late-onset Pompe disease: a prospective cohort study. Muscle Nerve 38(4):1236\u20131245. https:\/\/doi.org\/10.1002\/mus.21025. (PMID: 18816591)","journal-title":"Muscle Nerve"},{"issue":"2","key":"13206_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.nmd.2008.11.007","volume":"19","author":"NE Van der Beek","year":"2009","unstructured":"Van der Beek NE, Hagemans ML, Reuser AJ et al (2009) Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease. Neuromuscul Disord 19(2):113\u2013117. https:\/\/doi.org\/10.1016\/j.nmd.2008.11.007. (PMID: 19084399)","journal-title":"Neuromuscul Disord"},{"issue":"1\u20132","key":"13206_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neurol.2022.12.004","volume":"179","author":"C Gu\u00e9my","year":"2023","unstructured":"Gu\u00e9my C, Lafor\u00eat P (2023) The new horizons for treatment of Late-Onset Pompe Disease (LOPD). Rev Neurol (Paris) 179(1\u20132):81\u201389. https:\/\/doi.org\/10.1016\/j.neurol.2022.12.004. (PMID: 36609019)","journal-title":"Rev Neurol (Paris)"},{"issue":"6","key":"13206_CR8","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/jimd.12272","volume":"43","author":"C Semplicini","year":"2020","unstructured":"Semplicini C, De Antonio M, Taouagh N, French Pompe Study Group et al (2020) Long-term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: prospective analysis from the French Pompe Registry. J Inherit Metab Dis 43(6):1219\u20131231. https:\/\/doi.org\/10.1002\/jimd.12272. (PMID: 32515844)","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"13206_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16223","volume":"31","author":"A Lika","year":"2024","unstructured":"Lika A, Andrinopoulou ER, van der Beek NE et al (2024) Establishing how much improvement in lung function and distance walked is clinically important for adult patients with Pompe disease. Eur J Neurol 31(5):e16223. https:\/\/doi.org\/10.1111\/ene.16223. (PMID: 38375606)","journal-title":"Eur J Neurol"},{"issue":"1","key":"13206_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s13023-024-03156-3","volume":"19","author":"KG Claeys","year":"2024","unstructured":"Claeys KG, Kushlaf H, Raza S et al (2024) Minimal clinically important differences in six-minute walking distance in late-onset Pompe disease. Orphanet J Rare Dis 19(1):154. https:\/\/doi.org\/10.1186\/s13023-024-03156-3. (PMID: 38605392; PMCID: PMC11008008)","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"13206_CR11","doi-asserted-by":"publisher","first-page":"334","DOI":"10.3390\/cells11030334","volume":"11","author":"KG Claeys","year":"2022","unstructured":"Claeys KG, D\u2019Hondt A, Fache L et al (2022) Six-minute walk distance is a useful outcome measure to detect motor decline in treated late-onset Pompe disease patients. Cells 11(3):334. https:\/\/doi.org\/10.3390\/cells11030334. (PMID: 35159144; PMCID: PMC8834389)","journal-title":"Cells"},{"key":"13206_CR12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1164\/rccm.166.4.518","volume":"166","author":"American Thoracic Society\/European Respiratory Society","year":"2002","unstructured":"American Thoracic Society\/European Respiratory Society (2002) ATS\/ERS statement on respiratory muscle testing. Am J Respir Crit Care Med 166:518\u2013624","journal-title":"Am J Respir Crit Care Med"},{"key":"13206_CR13","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/ehjci\/jex244","volume":"18","author":"M Galderisi","year":"2017","unstructured":"Galderisi M, Cosyns B, Edvardsen T et al (2017) Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European association of cardiovascular imaging. Eur Heart J Cardiovasc Imaging 18:1301\u20131310","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"11","key":"13206_CR14","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1002\/humu.23878","volume":"40","author":"AJJ Reuser","year":"2019","unstructured":"Reuser AJJ, van der Ploeg AT, Chien YH, On Behalf of the Pompe Registry Sites et al (2019) GAA variants and phenotypes among 1079 patients with Pompe disease: Data from the Pompe Registry. Hum Mutat 40(11):2146\u20132164. https:\/\/doi.org\/10.1002\/humu.23878. (PMID: 31342611; PMCID: PMC6852536)","journal-title":"Hum Mutat"},{"key":"13206_CR15","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ebiom.2019.03.048","volume":"43","author":"AJ Bergsma","year":"2019","unstructured":"Bergsma AJ, In\u2019t Groen SLM, van den Dorpel JJA et al (2019) A genetic modifier of symptom onset in Pompe disease. EBioMedicine 43:553\u2013561. https:\/\/doi.org\/10.1016\/j.ebiom.2019.03.048. (PMID: 30922962; PMCID: PMC6562017)","journal-title":"EBioMedicine"},{"issue":"15","key":"13206_CR16","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","volume":"362","author":"AT van der Ploeg","year":"2010","unstructured":"van der Ploeg AT, Clemens PR, Corzo D et al (2010) A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease. N Engl J Med 362(15):1396\u20131406. https:\/\/doi.org\/10.1056\/NEJMoa0909859. (PMID: 20393176)","journal-title":"N Engl J Med"},{"issue":"12","key":"13206_CR17","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/S1474-4422(21)00241-6","volume":"20","author":"J Diaz-Manera","year":"2021","unstructured":"Diaz-Manera J, Kishnani PS, Kushlaf H, COMET Investigator Group et al (2021) Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial. Lancet Neurol 20(12):1012\u20131026. https:\/\/doi.org\/10.1016\/S1474-4422(21)00241-6. (Erratum in: Lancet Neurol. 2022 Apr; 21(4):e4. 10.1016\/S1474-4422(22)00088-6. PMID: 34800399)","journal-title":"Lancet Neurol"},{"issue":"8","key":"13206_CR18","doi-asserted-by":"publisher","first-page":"5433","DOI":"10.1007\/s00415-024-12489-9","volume":"271","author":"KI Berger","year":"2024","unstructured":"Berger KI, Chien YH, Dubrovsky A et al (2024) Changes in forced vital capacity over \u2264 13 years among patients with late-onset Pompe disease treated with alglucosidase alfa: new modeling of real-world data from the Pompe Registry. J Neurol 271(8):5433\u20135446. https:\/\/doi.org\/10.1007\/s00415-024-12489-9. (PMID: 38896264; PMCID: PMC11319528)","journal-title":"J Neurol"},{"key":"13206_CR19","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.jval.2022.09.100","volume":"25","author":"M Fournier","year":"2022","unstructured":"Fournier M, Caro JJ, Coughlan A et al (2022) CO20 predicted time to wheelchair and ventilation events comparing avalglucosidase alfa (AVA) versus (vs) alglucosidase alfa (ALG) using a model of late-onset Pompe disease (LOPD). Value Health 25:S21. https:\/\/doi.org\/10.1016\/j.jval.2022.09.100","journal-title":"Value Health"},{"issue":"6","key":"13206_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1750-1172-6-34","volume":"1","author":"D G\u00fcng\u00f6r","year":"2011","unstructured":"G\u00fcng\u00f6r D, de Vries JM, Hop WC et al (2011) Survival and associated factors in 268 adults with Pompe disease prior to treatment with enzyme replacement therapy. Orphanet J Rare Dis 1(6):34. https:\/\/doi.org\/10.1186\/1750-1172-6-34. (PMID: 21631931;PMCID: PMC3135500)","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"13206_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/1750-1172-8-49","volume":"27","author":"D G\u00fcng\u00f6r","year":"2013","unstructured":"G\u00fcng\u00f6r D, Kruijshaar ME, Plug I et al (2013) Impact of enzyme replacement therapy on survival in adults with Pompe disease: results from a prospective international observational study. Orphanet J Rare Dis 27(8):49. https:\/\/doi.org\/10.1186\/1750-1172-8-49. (PMID: 23531252; PMCID: PMC3623847)","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"13206_CR22","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3390\/cimb45040186","volume":"45","author":"P De Filippi","year":"2023","unstructured":"De Filippi P, Errichiello E, Toscano A et al (2023) Distribution of exonic variants in glycogen synthesis and catabolism genes in Late Onset Pompe Disease (LOPD). Curr Issues Mol Biol 45(4):2847\u20132860. https:\/\/doi.org\/10.3390\/cimb45040186. (PMID: 37185710; PMCID: PMC10136686)","journal-title":"Curr Issues Mol Biol"},{"issue":"1\u20132","key":"13206_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ymgme.2007.05.011","volume":"92","author":"L Gort","year":"2007","unstructured":"Gort L, Coll MJ, Chab\u00e1s A (2007) Glycogen storage disease type II in Spanish patients: high frequency of c.1076\u20131G>C mutation. Mol Genet Metab 92(1\u20132):183\u2013187. https:\/\/doi.org\/10.1016\/j.ymgme.2007.05.011. (PMID: 17616415)","journal-title":"Mol Genet Metab"},{"issue":"4","key":"13206_CR24","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s00415-015-7664-0","volume":"262","author":"F Montagnese","year":"2015","unstructured":"Montagnese F, Barca E, Musumeci O et al (2015) Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment. J Neurol 262(4):968\u2013978. https:\/\/doi.org\/10.1007\/s00415-015-7664-0. (PMID: 25673129)","journal-title":"J Neurol"},{"issue":"10","key":"13206_CR25","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/humu.20374","volume":"27","author":"AL Montalvo","year":"2006","unstructured":"Montalvo AL, Bembi B, Donnarumma M et al (2006) Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II. Hum Mutat 27(10):999\u20131006. https:\/\/doi.org\/10.1002\/humu.20374. (PMID: 16917947)","journal-title":"Hum Mutat"},{"issue":"8","key":"13206_CR26","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1007\/s10072-020-04316-6","volume":"41","author":"P Ruggeri","year":"2020","unstructured":"Ruggeri P, Lo Monaco L, Musumeci O et al (2020) Ultrasound assessment of diaphragm function in patients with late-onset Pompe disease. Neurol Sci 41(8):2175\u20132184. https:\/\/doi.org\/10.1007\/s10072-020-04316-6. (PMID: 32162165)","journal-title":"Neurol Sci"},{"key":"13206_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V et al (2005) Standardisation of spirometry. Eur Respir J 26:319\u2013338","journal-title":"Eur Respir J"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13206-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13206-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T06:01:32Z","timestamp":1757224892000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13206-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["13206"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13206-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,11]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors did not receive support from any organization for the submitted work. TM, LV, OM, GS, GR, MF, LM, AT have received advisory board honoraria from Sanofi and\/or Amicus. TM, GG, PA, LV, OM, SR, LR, AF, RB, SS, CS, GS, GR, LVE, PT, EP, MF, GD, GC, LM, AB, GCR, AT have received congress participation support from Sanofi and\/or Amicus.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"503"}}